This paper is in the following e-collection/theme issue:

Scoping Review Protocols (184) Digital Health Reviews (1315) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (158) Pharmacovigilance (136) Infodemiology and Infoveillance (1363) Infoveillance, Infodemiology, Digital Disease Surveillance, Infodemic Management (1048)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/47068, first published .
The Role of Social Media for Identifying Adverse Drug Events Data in Pharmacovigilance: Protocol for a Scoping Review

The Role of Social Media for Identifying Adverse Drug Events Data in Pharmacovigilance: Protocol for a Scoping Review

The Role of Social Media for Identifying Adverse Drug Events Data in Pharmacovigilance: Protocol for a Scoping Review

Authors of this article:

Su Golder1 Author Orcid Image ;   Karen O'Connor2 Author Orcid Image ;   Yunwen Wang3 Author Orcid Image ;   Graciela Gonzalez Hernandez3 Author Orcid Image
Article Authors Cited by (4) Tweetations (4) Metrics

Journals

  1. Phillips B. Towards evidence-based medicine for paediatricians. Archives of Disease in Childhood 2024;109(2):167.2 View
  2. Dong F, Guo W, Liu J, Patterson T, Hong H. BERT-based language model for accurate drug adverse event extraction from social media: implementation, evaluation, and contributions to pharmacovigilance practices. Frontiers in Public Health 2024;12 View
  3. Golder S, O'Connor K, Wang Y, Klein A, Gonzalez Hernandez G. The Value of Social Media Analysis for Adverse Events Detection and Pharmacovigilance: Scoping Review. JMIR Public Health and Surveillance 2024;10:e59167 View
  4. Liguori V, Anatriello A, Cantone A, Nicoletti M, Argenziano G, Scavone C, Pieretti G. The Use of Botulinum Toxin Type A and the Occurrence of Anaphylaxis: A Descriptive Analysis of Data from the European Spontaneous Reporting System. Aesthetic Plastic Surgery 2024 View